The ‘Transparency Effect’ in Pharmaceutical ESG Reports
As the pharmaceutical sector has become increasingly competitive, companies have adopted a plethora of strategies and practices not only to publicise their products but also to be perceived by stakeholders as transparent and, by way of implication, honest and ethical. Drawing on a corpus of English-...
Saved in:
| Main Authors: | Andrea Fenice, Renzo Mocini |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Department of Foreign Languages and Literatures at the University of Verona
2025-06-01
|
| Series: | Iperstoria |
| Subjects: | |
| Online Access: | https://iperstoria.it/article/view/1510 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ESG Reporting and Systemic Risk: Evidence from European Markets
by: Iulia Lupu, et al.
Published: (2025-05-01) -
La face cachée de l’injonction de transparence
by: Jean-Pierre Cavaillé
Published: (2014-12-01) -
The Impact of Sanctions on the Level of ESG Transparency in russian Companies after the Start of the Special Military Operation
by: B. S. Bataeva, et al.
Published: (2024-12-01) -
Towards the Right to Cinematic Opacity: Navigating Transparency, Migration and Whiteness in Europe
by: Nadica Denić
Published: (2025-06-01) -
Ensuring Transparency of ESG Transformation of Corporations (Using the Example of Retail Companies)
by: B. S. Bataeva
Published: (2024-08-01)